Stouch B - Search Results

1

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats.

Li X, Warmington KS, Niu QT, Asuncion FJ, Barrero M, Grisanti M, Dwyer D, Stouch B, Thway TM, Stolina M, Ominsky MS, Kostenuik PJ, Simonet WS, Paszty C, Ke HZ. Li X, et al. Among authors: stouch b. J Bone Miner Res. 2010 Dec;25(12):2647-56. doi: 10.1002/jbmr.182. Epub 2010 Jul 16. J Bone Miner Res. 2010. PMID: 20641040 Free article.

2

Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats.

Capparelli C, Morony S, Warmington K, Adamu S, Lacey D, Dunstan CR, Stouch B, Martin S, Kostenuik PJ. Capparelli C, et al. Among authors: stouch b. J Bone Miner Res. 2003 May;18(5):852-8. doi: 10.1359/jbmr.2003.18.5.852. J Bone Miner Res. 2003. PMID: 12733724 Free article.

3

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength.

Ominsky MS, Vlasseros F, Jolette J, Smith SY, Stouch B, Doellgast G, Gong J, Gao Y, Cao J, Graham K, Tipton B, Cai J, Deshpande R, Zhou L, Hale MD, Lightwood DJ, Henry AJ, Popplewell AG, Moore AR, Robinson MK, Lacey DL, Simonet WS, Paszty C. Ominsky MS, et al. Among authors: stouch b. J Bone Miner Res. 2010 May;25(5):948-59. doi: 10.1002/jbmr.14. J Bone Miner Res. 2010. PMID: 20200929 Free article.

4

Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.

Ominsky MS, Stouch B, Schroeder J, Pyrah I, Stolina M, Smith SY, Kostenuik PJ. Ominsky MS, et al. Among authors: stouch b. Bone. 2011 Aug;49(2):162-73. doi: 10.1016/j.bone.2011.04.001. Epub 2011 Apr 9. Bone. 2011. PMID: 21497676

5

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody.

Padhi D, Jang G, Stouch B, Fang L, Posvar E. Padhi D, et al. Among authors: stouch b. J Bone Miner Res. 2011 Jan;26(1):19-26. doi: 10.1002/jbmr.173. J Bone Miner Res. 2011. PMID: 20593411 Free article. Clinical Trial.

6

Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study.

Padhi D, Allison M, Kivitz AJ, Gutierrez MJ, Stouch B, Wang C, Jang G. Padhi D, et al. Among authors: stouch b. J Clin Pharmacol. 2014 Feb;54(2):168-78. doi: 10.1002/jcph.239. Epub 2013 Dec 11. J Clin Pharmacol. 2014. PMID: 24272917 Clinical Trial.

7

Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction.

Dong JQ, Salinger DH, Endres CJ, Gibbs JP, Hsu CP, Stouch BJ, Hurh E, Gibbs MA. Dong JQ, et al. Clin Pharmacokinet. 2011 Feb;50(2):131-42. doi: 10.2165/11537430-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21241072

8

Application of DBS sampling in combination with LC-MS/MS for pharmacokinetic evaluation of a compound with species-specific blood-to-plasma partitioning.

Xu G, Chen JS, Phadnis R, Huang T, Uyeda C, Soto M, Stouch B, Wells MC, James CA, Carlson TJ. Xu G, et al. Among authors: stouch b. Bioanalysis. 2012 Aug;4(16):2037-47. doi: 10.4155/bio.12.167. Bioanalysis. 2012. PMID: 22946919

9

A Dual-Chamber Leadless Pacemaker.

Knops RE, Reddy VY, Ip JE, Doshi R, Exner DV, Defaye P, Canby R, Bongiorni MG, Shoda M, Hindricks G, Neužil P, Rashtian M, Breeman KTN, Nevo JR, Ganz L, Hubbard C, Cantillon DJ; Aveir DR i2i Study Investigators. Knops RE, et al. N Engl J Med. 2023 Jun 22;388(25):2360-2370. doi: 10.1056/NEJMoa2300080. Epub 2023 May 20. N Engl J Med. 2023. PMID: 37212442

10

Transcatheter Repair for Patients with Tricuspid Regurgitation.

Sorajja P, Whisenant B, Hamid N, Naik H, Makkar R, Tadros P, Price MJ, Singh G, Fam N, Kar S, Schwartz JG, Mehta S, Bae R, Sekaran N, Warner T, Makar M, Zorn G, Spinner EM, Trusty PM, Benza R, Jorde U, McCarthy P, Thourani V, Tang GHL, Hahn RT, Adams DH; TRILUMINATE Pivotal Investigators. Sorajja P, et al. N Engl J Med. 2023 May 18;388(20):1833-1842. doi: 10.1056/NEJMoa2300525. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876753 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page